| Issue Date |
Title |
Author(s) |
| Jan-2022 |
Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection |
Wang, Yifan;Duan, Fugang;Zhu, Zhu;Yu, Meng;Jia, Xiaodong;Dai, Hui;Wang, Pingzhang;Qiu, Xiaoyan;Lu, Yinying;Huang, Jing |
| Dec-2022 |
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors |
Lei, Jin;Yan, Tao;Zhang, Linzhi;Chen, Bowen;Cheng, Jiamin;Gao, Xiaoqiang;Liu, Zherui;Li, Yinyin;Zuo, Shi;Lu, Yinying |
| 1-Jun-2022 |
Efficacy and safety in advanced hepatocellular carcinoma using atezolizumab plus bevacizumab combined with interventional therapy: A retrospective analysis of real-world evidence. |
Cheng, Jiamin;Chen, Bowen;Jing, Yi;Lu, Yinying |
| Oct-2021 |
EFFICACY AND SAFETY OF LENVATINIB COMBINED WITH DIFFERENT ANTI-PD-1 ANTIBODY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL WORLD EVIDENCE BASED RETROSPECTIVE STUDY |
Chen, Bowen;Zhang, Linzhi;Cheng, Jiamin, Sr.;Yan, Tao;Lu, Yinying |
| 2022 |
Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study |
Chen, Bowen;Lei, Jin;Zhao, Haitao;Dong, Jinghui;Zeng, Zhen;Li, Yinyin;Yu, Lingxiang;Zhou, Lin;Jia, Aiying;Lu, Yinying;Cheng, Jiamin |
| 9-Dec-2022 |
Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma |
Xie, Fucun;Chen, Bowen;Yang, Xu;Wang, Huaiyuan;Zhang, Ge;Wang, Yanyu;Wang, Yunchao;Zhang, Nan;Xue, Jingnan;Long, Junyu;Li, Yiran;Sun, Huishan;Xun, Ziyu;Liu, Kai;Chen, Xiangqi;Song, Yang;Yang, Xiaobo;Lu, Zhenhui;Mao, Yilei;Sang, Xinting;Lu, Yinying;Zhao, Haitao |
| 2019 |
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes |
Xue, Ruidong;Chen, Lu;Zhang, Chong;Fujita, Masashi;Li, Ruoyan;Yan, Shu-Mei;Ong, Choon Kiat;Liao, Xiwen;Gao, Qiang;Sasagawa, Shota;Li, Yanmeng;Wang, Jincheng;Guo, Hua;Huang, Qi-Tao;Zhong, Qian;Tan, Jing;Qi, Lisha;Gong, Wenchen;Hong, Zhixian;Li, Meng;Zhao, Jingmin;Peng, Tao;Lu, Yinying;Lim, Kiat Hon Tony;Boot, Arnoud;Ono, Atushi;Chayama, Kazuaki;Zhang, Zemin;Rozen, Steve George;Teh, Bin Tean;Wang, Xin Wei;Nakagawa, Hidewaki;Zeng, Mu-Sheng;Bai, Fan;Zhang, Ning |
| 8-Mar-2022 |
Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6 |
Liu, Zherui;Li, Yinyin;Li, Chen;Lei, Guanglin;Zhou, Lin;Chen, Xiangling;Jia, Xiaodong;Lu, Yinying |
| 1-Jun-2022 |
Lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma: A large real-world study from two centers. |
Yang, Xu;Chen, Bowen;Wang, Yanyu;Wang, Yunchao;Long, Junyu;Zhang, Nan;Xue, Jinnan;Xun, Ziyu;Zhang, Linzhi;Cheng, Jiamin;Lei, Jin;Pan, Jie;Hu, Ke;Guan, Mei;Huo, Li;Mao, Yilei;Sang, Xinting;Lu, Yinying;Zhao, Hai-Tao |
| 2018 |
A New Nomogram Predicting Overall Survival of Patients with Intrahepatic Cholangiocarcinoma |
Zhang, Ning;Lu, Shanshan;Wu, Yao;Hong, Na;Lu, Yinying |
| 2018 |
A New Nomogram Predicting Overall Survival of Patients with Intrahepatic Cholangiocarcinoma |
Zhang, Ning;Lu, Shanshan;Wu, Yao;Hong, Na;Lu, Yinying |
| 5-Jul-2022 |
A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire |
Yu, Meng;Zhu, Zhu;Wang, Yanqun;Wang, Pingzhang;Jia, Xiaodong;Wang, Jie;Liu, Lei;Liu, Wanbing;Zheng, Yaqiong;Kou, Guomei;Xu, Weiyan;Huang, Jing;Lu, Fengmin;Zou, Xiajuan;Zheng, Shangen;Lu, Yinying;Zhao, Jincun;Dai, Hui;Qiu, Xiaoyan |
| 28-Feb-2022 |
A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
Duan, Fugang;Wang, Yifan;Chen, Taoyu;Zhu, Zhu;Yu, Meng;Dai, Hui;Zheng, Shangen;Lu, Yinying;Li, Tingting;Qiu, Xiaoyan |
| Feb-2023 |
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients |
Yang, Xu;Chen, Bowen;Wang, Yanyu;Wang, Yunchao;Long, Junyu;Zhang, Nan;Xue, Jingnan;Xun, Ziyu;Zhang, Linzhi;Cheng, Jiamin;Lei, Jin;Sun, Huishan;Li, Yiran;Lin, Jianzhen;Xie, Fucun;Wang, Dongxu;Pan, Jie;Hu, Ke;Guan, Mei;Huo, Li;Shi, Jie;Yu, Lingxiang;Zhou, Lin;Zhou, Jinxue;Lu, Zhenhui;Yang, Xiaobo;Mao, Yilei;Sang, Xinting;Lu, Yinying;Zhao, Haitao |
| Jul-2022 |
Risk factors for hepatic encephalopathy in hepatocellular carcinoma after sorafenib or lenvatinib treatment: a real-world study |
Chen, Bowen;Zhang, Linzhi;Cheng, Jiamin;Yang, Xu;Lei, Jin;Wu, Tong;Yan, Tao;Li, Yinyin;Lu, Yinying |
| Apr-2020 |
Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation |
Wang, Panpan;Liu, Lu;Liu, Aijun;Yan, Liming;He, Yong;Shen, Shu;Hu, Mingxu;Guo, Yu;Liu, Haiguang;Liu, Chuang;Lu, Yinying;Wang, Peiyi;Deng, Fei;Rao, Zihe;Lou, Zhiyong |
| 9-Dec-2022 |
TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure |
Lei, Jin;Chen, Bowen;Song, Meiru;Zhang, Linzhi;Zhang, Xinfeng;Gao, Xiaoqiang;Li, Yinyin;Lu, Yinying;Zuo, Shi |
